Literature DB >> 1723404

Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.

D A Dance, V Wuthiekanun, W Chaowagul, Y Suputtamongkol, N J White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1723404     DOI： 10.1093/jac/28.2.321

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  10 in total

1.  In vitro activity of doripenem against Burkholderia pseudomallei.

Authors:  Visanu Thamlikitkul; Suwanna Trakulsomboon
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

2.  Bacteriophage-associated genes responsible for the widely divergent phenotypes of variants of Burkholderia pseudomallei strain MSHR5848.

Authors:  David DeShazer; Sean Lovett; Joshua Richardson; Galina Koroleva; Kathleen Kuehl; Kei Amemiya; Mei Sun; Patricia Worsham; Susan Welkos
Journal:  J Med Microbiol       Date:  2019-01-10       Impact factor: 2.472

3.  In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.

Authors:  D J Kenny; P Russell; D Rogers; S M Eley; R W Titball
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

4.  In vitro activity of tigecycline against Burkholderia pseudomallei and Burkholderia thailandensis.

Authors:  Visanu Thamlikitkul; Suwanna Trakulsomboon
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei.

Authors:  I-Ching Sam; Kah Heng See; Savithri D Puthucheary
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

6.  Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition.

Authors:  Chanwit Tribuddharat; Richard A Moore; Patricia Baker; Donald E Woods
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

7.  Characterization of in vitro phenotypes of Burkholderia pseudomallei and Burkholderia mallei strains potentially associated with persistent infection in mice.

Authors:  R C Bernhards; C K Cote; K Amemiya; D M Waag; C P Klimko; P L Worsham; S L Welkos
Journal:  Arch Microbiol       Date:  2016-10-13       Impact factor: 2.552

8.  Two stable variants of Burkholderia pseudomallei strain MSHR5848 express broadly divergent in vitro phenotypes associated with their virulence differences.

Authors:  A A Shea; R C Bernhards; C K Cote; C J Chase; J W Koehler; C P Klimko; J T Ladner; D A Rozak; M J Wolcott; D P Fetterer; S J Kern; G I Koroleva; S P Lovett; G F Palacios; R G Toothman; J A Bozue; P L Worsham; S L Welkos
Journal:  PLoS One       Date:  2017-02-10       Impact factor: 3.240

9.  Rapid antimicrobial susceptibility testing and β-lactam-induced cell morphology changes of Gram-negative biological threat pathogens by optical screening.

Authors:  Heather P McLaughlin; David Sue
Journal:  BMC Microbiol       Date:  2018-12-18       Impact factor: 3.605

10.  A simple scoring system to differentiate between relapse and re-infection in patients with recurrent melioidosis.

Authors:  Direk Limmathurotsakul; Wipada Chaowagul; Narisara Chantratita; Vanaporn Wuthiekanun; Mayurachat Biaklang; Sarinna Tumapa; Nicholas J White; Nicholas P J Day; Sharon J Peacock
Journal:  PLoS Negl Trop Dis       Date:  2008-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.